Reprogramming with small molecules instead of exogenous transcription factors

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Lin, Tongxiang ^a,b   Wu, Shouhai ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLSEROTONIN; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; ASCORBIC ACID; AZACITIDINE; BAYK 8644; BUTYRIC ACID; CALCIUM CHANNEL STIMULATING AGENT; CHEMICAL COMPOUND; FORSKOLIN; KENPAULLONE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; SMALL MOLECULE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; TRANYLCYPROMINE; TRICHOSTATIN A; UNCLASSIFIED DRUG; UVOMORULIN; VALPROIC ACID; VORINOSTAT;

ADULT STEM CELL; ARTICLE; CELL AGING; CELL DIFFERENTIATION; CELLULAR PARAMETERS; CHEMICALLY INDUCED PLURIPOTENT STEM CELL; DNA MODIFICATION; EMBRYONIC STEM CELL; EPIGENETICS; EXTRACELLULAR MATRIX; HISTONE METHYLATION; HUMAN; INTRACELLULAR SIGNALING; MEDICAL RESEARCH; MESENCHYMAL EPITHELIAL TRANSITION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REPROGRAMMING EFFICIENCY; REPROGRAMMING QUALITY; SOMATIC CELL; WNT SIGNALING PATHWAY;

EID: 84928152056     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/794632     Document Type: Article

References (81)

1. K. Takahashi, K. Tanabe, M. Ohnuki et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors, " Cell, vol. 131, no. 5, pp. 861-872, 2007.
2. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., "Induced pluripotent stem cell lines derived from human somatic cells, " Science, vol. 318, pp. 1917-1920, 2007.
3. M. H. Chin, M. J. Mason, W. Xie et al., "Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures, " Cell Stem Cell, vol. 5, no. 1, pp. 111-123, 2009.
4. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, " Cell, vol. 126, no. 4, pp. 663-676, 2006.
5. K. Takahashi, K. Okita, M. Nakagawa, and S. Yamanaka, "Induction of pluripotent stem cells from fibroblast cultures, " Nature Protocols, vol. 2, no. 12, pp. 3081-3089, 2007.
6. K. Okita, T. Ichisaka, and S. Yamanaka, "Generation of germline-competent induced pluripotent stem cells, " Nature, vol. 448, no. 7151, pp. 313-317, 2007.
7. Y. Ohi, H. Qin, C. Hong et al., "Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells, " Nature Cell Biology, vol. 13, no. 5, pp. 541-549, 2011.
8. H. Xu, B. A. Yi, H. Wu et al., "Highly efficient derivation of ventricular cardiomyocytes frominduced pluripotent stem cells with a distinct epigenetic signature, " Cell Research, vol. 22, no. 1, pp. 142-154, 2012.
9. O. Bar-Nur, H. A. Russ, S. Efrat, and N. Benvenisty, "Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells, " Cell Stem Cell, vol. 9, no. 1, pp. 17-23, 2011.
10. S. B. Lee, D. Seo, D. Choi et al., "Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells, " Stem Cells, vol. 30, no. 5, pp. 997-1007, 2012.
11. R. Lister, M. Pelizzola, Y. S. Kida et al., "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, " Nature, vol. 471, no. 7336, pp. 68-73, 2011.
12. T. Zhao, Z.-N. Zhang, Z. Rong, and Y. Xu, "Immunogenicity of induced pluripotent stem cells, " Nature, vol. 474, no. 7350, pp. 212-215, 2011.
13. Y. H. Loh, J. C. Yang, A. de losAngeles et al., "Excision of a viral reprogramming cassette by delivery of synthetic CremRNA, " in Current Protocols in Stem Cell Biology, chapter 4, unit 4A. 5, John Wiley and Sons, Hoboken, NJ, USA, 2012.
14. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen, "Virus-free induction of pluripotency and subsequent excision of reprogramming factors, " Nature, vol. 458, no. 7239, pp. 771-775, 2009.
15. K. Woltjen, I. P. Michael, P. Mohseni et al., "PiggyBac transposition reprograms fibroblasts to induced pluripotent stemcells, " Nature, vol. 458, no. 7239, pp. 766-770, 2009.
16. M. Stadtfeld, M. Nagaya, J. Utikal, G. Weir, and K. Hochedlinger, "Induced pluripotent stem cells generated without viral integration, " Science, vol. 322, no. 5903, pp. 945-949, 2008.
17. W. Zhou and C. R. Freed, "Adenoviral gene delivery can reprogramhuman fibroblasts to induced pluripotent stemcells, " Stem Cells, vol. 27, no. 11, pp. 2667-2674, 2009.
18. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa, "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, " Proceedings of the Japan Academy Series B: Physical and Biological Sciences, vol. 85, no. 8, pp. 348-362, 2009.
19. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka, "Generation of mouse induced pluripotent stem cells without viral vectors, " Science, vol. 322, no. 5903, pp. 949-953, 2008.
20. J. Yu, K. Hu, K. Smuga-Otto et al., "Human induced pluripotent stem cells free of vector and transgene sequences, " Science, vol. 324, no. 5928, pp. 797-801, 2009.
21. K. Okita, Y. Matsumura, Y. Sato et al., "A more efficient method to generate integration-free human iPS cells, " Nature Methods, vol. 8, pp. 409-412, 2011.
22. F. Jia, K. D. Wilson, N. Sun et al., "A nonviral minicircle vector for deriving human iPS cells, " Nature Methods, vol. 7, pp. 197-199, 2010.
23. H. Y. Park, E. H. Noh, H.-M. Chung, M.-J. Kang, E. Y. Kim, and S. P. Park, "Efficient generation of virus-free iPS cells using liposomal magnetofection, " PLoS ONE, vol. 7, no. 9, Article ID e45812, 2012.
24. H. Zhou, S. Wu, J. Y. Joo et al., "Generation of induced pluripotent stem cells using recombinant proteins, " Cell Stem Cell, vol. 4, no. 5, pp. 381-384, 2009.
25. D. Kim, C.-H. Kim, J.-I. Moon et al., "Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, " Cell Stem Cell, vol. 4, no. 6, pp. 472-476, 2009.
26. L. Warren, P. D. Manos, T. Ahfeldt et al., "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with syntheticmodifiedmRNA, " Cell Stem Cell, vol. 7, no. 5, pp. 618-630, 2010.
27. P. Hou, Y. Li, X. Zhang et al., "Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds, " Science, vol. 341, no. 6146, pp. 651-654, 2013.
28. N. Maherali, R. Sridharan, W. Xie et al., "Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution, " Cell Stem Cell, vol. 1, no. 1, pp. 55-70, 2007.
29. T. S. Mikkelsen, J. Hanna, X. Zhang et al., "Dissecting direct reprogramming through integrative genomic analysis, " Nature, vol. 454, no. 7200, pp. 49-55, 2008.
30. R. Sridharan, J. Tchieu, M. J. Mason et al., "Role of the murine reprogramming factors in the induction of pluripotency, " Cell, vol. 136, no. 2, pp. 364-377, 2009.
31. D. Huangfu, R. Maehr, W. Guo et al., "Induction of pluripotent stem cells by defined factors is greatly improved by smallmolecule compounds, " Nature Biotechnology, vol. 26, no. 7, pp. 795-797, 2008.
32. Y. Shi, C. Desponts, J. T. Do, H. S. Hahm, H. R. Schöler, and S. Ding, "Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds, " Cell Stem Cell, vol. 3, no. 5, pp. 568-574, 2008.
33. Y. Shi, J. T. Do, C. Desponts, H. S. Hahm, H. R. Schöler, and S. Ding, "A combined chemical and genetic approach for the generation of induced pluripotent stemcells, " Cell Stem Cell, vol. 2, pp. 525-528, 2008.
34. B. Nie, H. Wang, T. Laurent, and S. Ding, "Cellular reprogramming: a small molecule perspective, " Current Opinion in Cell Biology, vol. 24, no. 6, pp. 784-792, 2012.
35. W. Li, H. Zhou, R. Abujarour et al., "Generation of humaninduced pluripotent stem cells in the absence of exogenous Sox2, " Stem Cells, vol. 27, no. 12, pp. 2992-3000, 2009.
36. R. D. Hawkins, G. C. Hon, L. K. Lee et al., "Distinct epigenomic landscapes of pluripotent and lineage-committed human cells, " Cell Stem Cell, vol. 6, no. 5, pp. 479-491, 2010.
37. J. Shu, C. Wu, Y. Wu et al., "Induction of pluripotency inmouse somatic cells with lineage specifiers, " Cell, vol. 153, no. 5, pp. 963-975, 2013.
38. F. Lluis, L. Ombrato, E. Pedone, S. Pepe, B. J. Merrill, and M. P. Cosma, "T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 11912-11917, 2011.
39. R. Zhao and G. Q. Daley, "From fibroblasts to iPS cells: induced pluripotency by defined factors, " Journal of Cellular Biochemistry, vol. 105, no. 4, pp. 949-955, 2008.
40. H. Niwa, "Wnt: what's Needed to maintain pluripotency?" Nature Cell Biology, vol. 13, no. 9, pp. 1024-1026, 2011.
41. A. Marson, R. Foreman, B. Chevalier et al., "Wnt signaling promotes reprogramming of somatic cells to pluripotency, " Cell Stem Cell, vol. 3, no. 2, pp. 132-135, 2008.
42. C. A. Lyssiotis, R. K. Foreman, J. Staerk et al., "Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 22, pp. 8912-8917, 2009.
43. J. D. Holland, A. Klaus, A. N. Garratt, and W. Birchmeier, "Wnt signaling in stemand cancer stem cells, " Current Opinion in Cell Biology, vol. 25, no. 2, pp. 254-264, 2013.
44. Y. Zhao, X. Yin, H. Qin et al., "Two supporting factors greatly improve the efficiency of human iPSC generation, " Cell Stem Cell, vol. 3, no. 5, pp. 475-479, 2008.
45. H. Hong, K. Takahashi, T. Ichisaka et al., "Suppression of induced pluripotent stem cell generation by the p53-p21 pathway, " Nature, vol. 460, no. 7259, pp. 1132-1135, 2009.
46. T. Kawamura, J. Suzuki, Y. V. Wang et al., "Linking the p53 tumour suppressor pathway to somatic cell reprogramming, " Nature, vol. 460, no. 7259, pp. 1140-1144, 2009.
47. H. Li, M. Collado, A. Villasante et al., "The Ink4/Arf locus is a barrier for iPS cell reprogramming, " Nature, vol. 460, no. 7259, pp. 1136-1139, 2009.
48. J. Utikal, J. M. Polo, M. Stadtfeld et al., "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells, " Nature, vol. 460, no. 7259, pp. 1145-1148, 2009.
49. R. M. Marión, K. Strati, H. Li et al., "A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity, " Nature, vol. 460, no. 7259, pp. 1149-1153, 2009.
50. V. Krizhanovsky and S. W. Lowe, "Stem cells: the promises and perils of p53, " Nature, vol. 460, no. 7259, pp. 1085-1086, 2009.
51. T. Lin, C. Chao, S. Saito et al., "p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression, " Nature Cell Biology, vol. 7, no. 2, pp. 165-171, 2005.
52. N. Shevde, "Stem cells: flexible friends, " Nature, vol. 483, no. 7387, pp. S22-S26, 2012.
53. M. A. Esteban, T. Wang, B. Qin et al., "Vitamin C enhances the generation of mouse and human induced pluripotent stem cells, " Cell Stem Cell, vol. 6, no. 1, pp. 71-79, 2010.
54. D. A. Robinton and G. Q. Daley, "The promise of induced pluripotent stem cells in research and therapy, " Nature, vol. 481, no. 7381, pp. 295-305, 2012.
55. A. Banito, S. T. Rashid, J. C. Acosta et al., "Senescence impairs successful reprogramming to pluripotent stem cells, " Genes and Development, vol. 23, no. 18, pp. 2134-2139, 2009.
56. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, "Understanding the warburg effect: the metabolic requirements of cell proliferation, " Science, vol. 324, no. 5930, pp. 1029-1033, 2009.
57. Y. Yoshida, K. Takahashi, K. Okita, T. Ichisaka, and S. Yamanaka, "Hypoxia enhances the generation of induced pluripotent stem cells, " Cell Stem Cell, vol. 5, no. 3, pp. 237-241, 2009.
58. A. Prigione, B. Fauler, R. Lurz, H. Lehrach, and J. Adjaye, "The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells, " Stem Cells, vol. 28, no. 4, pp. 721-733, 2010.
59. S. Zhu, W. Li, H. Zhou et al., "Reprogramming of human primary somatic cells by OCT4 and chemical compounds, " Cell Stem Cell, vol. 7, no. 6, pp. 651-655, 2010.
60. R. Li, J. Liang, S. Ni et al., "Amesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, " Cell Stem Cell, vol. 7, no. 1, pp. 51-63, 2010.
61. P. Samavarchi-Tehrani, A. Golipour, L. David et al., "Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming, " Cell Stem Cell, vol. 7, no. 1, pp. 64-77, 2010.
62. T. Lin, R. Ambasudhan, X. Yuan et al., "A chemical platformfor improved induction of human iPSCs, " Nature Methods, vol. 6, no. 11, pp. 805-808, 2009.
63. J. K. Ichida, J. Blanchard, K. Lam et al., "A small-molecule inhibitor of tgf-β signaling replaces sox2 in reprogramming by inducing Nanog, " Cell Stem Cell, vol. 5, no. 5, pp. 491-503, 2009.
64. X. Yuan, H. Wan, X. Zhao, S. Zhu, Q. Zhou, and S. Ding, "Brief report: combined chemical treatment enables Oct4-induced reprogramming frommouse embryonic fibroblasts, " StemCells, vol. 29, no. 3, pp. 549-553, 2011.
65. G. N. Pandian, S. Sato, C. Anandhakumar et al., "Identification of a small molecule that turns ON the pluripotency gene circuitry in human fibroblasts, " ACS Chemical Biology, vol. 9, no. 12, pp. 2729-2736, 2014.
66. P. Mali, B.-K. Chou, J. Yen et al., "Butyrate greatly enhances derivation of human induced pluripotent stemcells by promoting epigenetic remodeling and the expression of pluripotencyassociated genes, " Stem Cells, vol. 28, no. 4, pp. 713-720, 2010.
67. J. Lee, Y. Xia, M.-Y. Son et al., "A novel small molecule facilitates the reprogramming of human somatic cells into a pluripotent state and supports the maintenance of an undifferentiated state of human pluripotent stem cells, " Angewandte Chemie International Edition, vol. 51, no. 50, pp. 12509-12513, 2012.
68. Q. Wang, X. Xu, J. Li et al., "Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells, " Cell Research, vol. 21, no. 10, pp. 1424-1435, 2011.
69. D. A. Claassen, M. M. Desler, and A. Rizzino, "ROCKinhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells, " Molecular Reproduction and Development, vol. 76, no. 8, pp. 722-732, 2009.
70. Z. Li and T. M. Rana, "A kinase inhibitor screen identifies smallmolecule enhancers of reprogramming and iPS cell generation, " Nature Communications, vol. 3, article 1085, 2012.
71. T. Chen, L. Shen, J. Yu et al., "Rapamycin and other longevitypromoting compounds enhance the generation of mouse induced pluripotent stem cells, " Aging Cell, vol. 10, no. 5, pp. 908-911, 2011.
72. Y. Shi, M. Zou, E. Y. Baitei et al., "Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma, " Cancer Gene Therapy, vol. 15, no. 2, pp. 101-107, 2008.
73. Y. Li, Q. Zhang, X. Yin et al., "Generation of iPSCs frommouse fibroblasts with a single gene, Oct4, and small molecules, " Cell Research, vol. 21, no. 1, pp. 196-204, 2011.
74. J. Staerk, C. A. Lyssiotis, L. A. Medeiro et al., "Pan-src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells, " Angewandte Chemie-International Edition, vol. 50, no. 25, pp. 5734-5736, 2011.
75. J.-H. Moon, J. S. Heo, J. S. Kim et al., "Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1, " Cell Research, vol. 21, no. 9, pp. 1305-1315, 2011.
76. D.-W. Jung, W.-H. Kim, and D. R. Williams, "Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming, " ACS Chemical Biology, vol. 9, no. 1, pp. 80-95, 2014.
77. Z. Pasha, H. K. Haider, and M. Ashraf, "Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells, " PLoS ONE, vol. 6, no. 8, Article ID e23667, 2011.
78. S. Durnaoglu, S. Genc, and K. Genc, "Patient-specific pluripotent stem cells in neurological diseases, " Stem Cells International, vol. 2011, Article ID 212487, 17 pages, 2011.
79. L. H. Mak, S. N. Georgiades, E. Rosivatz et al., "Asmall molecule mimicking a phosphatidylinositol (4, 5)-bisphosphate binding pleckstrin homology domain, " ACS Chemical Biology, vol. 6, no. 12, pp. 1382-1390, 2011.
80. Q.-L. Ying, J. Wray, J. Nichols et al., "The ground state of embryonic stem cell self-renewal, " Nature, vol. 453, no. 7194, pp. 519-523, 2008.
81. B. Valamehr, M. Robinson, R. Abujarour et al., "Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stemcells, " StemCell Reports, vol. 2, no. 3, pp. 366-381, 2014.